US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
WO1996020012A2
(en)
*
|
1994-12-23 |
1996-07-04 |
Middlesex Sciences, Inc. |
Methods for preparing and purifying macromolecular conjugates
|
EP0914094A4
(en)
|
1996-03-28 |
2000-03-01 |
Univ Illinois |
MATERIALS AND METHOD FOR PRODUCING IMPROVED LIPOSOMAL AGENTS
|
US6217886B1
(en)
|
1997-07-14 |
2001-04-17 |
The Board Of Trustees Of The University Of Illinois |
Materials and methods for making improved micelle compositions
|
SE512663C2
(sv)
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
US6660301B1
(en)
|
1998-03-06 |
2003-12-09 |
Biosphere Medical, Inc. |
Injectable microspheres for dermal augmentation and tissue bulking
|
ATE283709T1
(de)
*
|
1998-03-06 |
2004-12-15 |
Biosepra Medical Inc |
Implantierbare partikel zur erhöhung des gewebevolumens und zur behandlung von gastroösophagalreflux, inkontinenz und hautfalten
|
US20070009605A1
(en)
*
|
1998-07-23 |
2007-01-11 |
Ignatious Francis X |
Encapsulation of water soluble peptides
|
WO2000004916A1
(en)
*
|
1998-07-23 |
2000-02-03 |
Societe De Conseils De Recherches Et D'applications Scientifiques Sas |
Encapsulation of water soluble peptides
|
US6270700B1
(en)
|
1998-07-23 |
2001-08-07 |
Societe De Conseils De Recherches Et D'applications Scientifiques, Sas |
Encapsulation of water soluble peptides
|
FR2784580B1
(fr)
|
1998-10-16 |
2004-06-25 |
Biosepra Inc |
Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci
|
EP1074248A1
(en)
*
|
1999-07-08 |
2001-02-07 |
Arnold Hilgers |
Delivery system for biological material
|
US8106098B2
(en)
*
|
1999-08-09 |
2012-01-31 |
The General Hospital Corporation |
Protein conjugates with a water-soluble biocompatible, biodegradable polymer
|
US6822086B1
(en)
|
1999-08-09 |
2004-11-23 |
The General Hospital Corporation |
Drug-carrier complexes and methods of use thereof
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
EP1267946A4
(en)
|
2000-02-28 |
2008-07-02 |
Genesegues Inc |
SYSTEM AND METHOD FOR ENCAPSULATING NANOCAPSULES
|
WO2001070289A2
(en)
|
2000-03-20 |
2001-09-27 |
Biosphere Medical, Inc. |
Injectable and swellable microspheres for tissue bulking
|
US6436424B1
(en)
|
2000-03-20 |
2002-08-20 |
Biosphere Medical, Inc. |
Injectable and swellable microspheres for dermal augmentation
|
US7338657B2
(en)
*
|
2001-03-15 |
2008-03-04 |
Biosphere Medical, Inc. |
Injectable microspheres for tissue construction
|
ES2551164T3
(es)
|
2000-03-24 |
2015-11-16 |
Biosphere Medical, Inc. |
Microesferas para embolización activa
|
SE517422C2
(sv)
*
|
2000-10-06 |
2002-06-04 |
Bioglan Ab |
Farmaceutiskt acceptabel stärkelse
|
SE517421C2
(sv)
|
2000-10-06 |
2002-06-04 |
Bioglan Ab |
Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
|
JP2004510730A
(ja)
|
2000-10-06 |
2004-04-08 |
ヤゴテック アーゲー |
非経口的投与可能な制御放出微粒子調製物
|
WO2002043580A2
(en)
|
2000-10-27 |
2002-06-06 |
Epic Therapeutics, Inc. |
Production of microspheres
|
SE518008C2
(sv)
*
|
2000-11-16 |
2002-08-13 |
Bioglan Ab |
Parenteralt administrerbara mikropartiklar och förfarande för framställning av desamma
|
SE518007C2
(sv)
|
2000-11-16 |
2002-08-13 |
Bioglan Ab |
Förfarande för framställning av mikropartiklar
|
US20070142325A1
(en)
*
|
2001-01-08 |
2007-06-21 |
Gustavsson Nils O |
Starch
|
JP4799749B2
(ja)
*
|
2001-03-29 |
2011-10-26 |
花王株式会社 |
樹脂複合体
|
CN103641892B
(zh)
*
|
2001-03-29 |
2015-06-17 |
药物协和公司 |
用于治疗组织炎症和癌变的鸟苷酸环化酶受体激动剂
|
WO2002100444A1
(en)
*
|
2001-06-08 |
2002-12-19 |
Biosphere Medical Inc. |
Colloidal metal labelled microparticles, their production and use
|
DE60226613D1
(de)
*
|
2001-08-16 |
2008-06-26 |
Baxter Int |
Darreichungsformen welche mikropartikel und treibgas enthalten
|
US7105181B2
(en)
*
|
2001-10-05 |
2006-09-12 |
Jagotec, Ag |
Microparticles
|
SE0201599D0
(sv)
*
|
2002-03-21 |
2002-05-30 |
Skyepharma Ab |
Microparticles
|
US7053134B2
(en)
*
|
2002-04-04 |
2006-05-30 |
Scimed Life Systems, Inc. |
Forming a chemically cross-linked particle of a desired shape and diameter
|
US20040038303A1
(en)
*
|
2002-04-08 |
2004-02-26 |
Unger Gretchen M. |
Biologic modulations with nanoparticles
|
AU2003245589A1
(en)
*
|
2002-06-21 |
2004-01-06 |
Reuven Avrohom Cyrulnik |
System and method for noninvasive diagnostic imaging
|
US20050142205A1
(en)
*
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
US20070092452A1
(en)
*
|
2003-07-18 |
2007-04-26 |
Julia Rashba-Step |
Methods for fabrication, uses, compositions of inhalable spherical particles
|
EP1646445A4
(en)
*
|
2003-07-18 |
2007-09-19 |
Baxter Int |
METHOD OF MANUFACTURING, USING AND COMPOSING SMALL BALLULAR PARTICLES PRODUCED BY CONTROLLED PHASE SEPARATION
|
US20050048127A1
(en)
*
|
2003-07-22 |
2005-03-03 |
Larry Brown |
Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
|
US9176121B2
(en)
*
|
2004-02-13 |
2015-11-03 |
Roche Diagnostics Hematology, Inc. |
Identification of blood elements using inverted microscopy
|
MXPA06012992A
(es)
|
2004-05-12 |
2007-02-12 |
Baxter Int |
Microesferas que comprenden proteina y que muestran inyectabilidad en altas concentraciones de este agente.
|
WO2005112885A2
(en)
|
2004-05-12 |
2005-12-01 |
Baxter International Inc. |
Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
|
US8728525B2
(en)
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
JP2007537284A
(ja)
|
2004-05-12 |
2007-12-20 |
バクスター インターナショナル インコーポレイテッド |
核酸マイクロスフェア、その生成および送達
|
EP2484344B1
(en)
|
2005-05-09 |
2016-02-10 |
Biosphere Medical, S.A. |
Compositions and methods of using microspheres and non-ionic contrast agents
|
US8017152B2
(en)
*
|
2005-05-27 |
2011-09-13 |
Stratosphere Pharma Ab |
Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
|
JP5756588B2
(ja)
|
2005-07-15 |
2015-07-29 |
ミセル テクノロジーズ、インコーポレイテッド |
制御されたモルホロジーの薬剤粉末を含むポリマーコーティング
|
US20090062909A1
(en)
|
2005-07-15 |
2009-03-05 |
Micell Technologies, Inc. |
Stent with polymer coating containing amorphous rapamycin
|
US20090099031A1
(en)
*
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
US7846445B2
(en)
*
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
US20070212703A1
(en)
*
|
2005-09-27 |
2007-09-13 |
Stemmer Willem P |
Proteinaceous pharmaceuticals and uses thereof
|
WO2007041190A2
(en)
*
|
2005-09-30 |
2007-04-12 |
The University Of Iowa Research Foundation |
Polymer-based delivery system for immunotherapy of cancer
|
ES2643140T3
(es)
*
|
2005-12-22 |
2017-11-21 |
Oakwood Laboratories L.L.C. |
Sistema de suministro de liberación lenta sublimable y procedimiento de realización del mismo
|
EP3363455A1
(en)
|
2005-12-30 |
2018-08-22 |
Zensun (Shanghai) Science & Technology, Co., Ltd. |
Extended release of neuregulin for improved cardiac function
|
RU2464973C2
(ru)
|
2006-01-24 |
2012-10-27 |
НексБио, Инк. |
Технология изготовления макромолекулярных микросфер
|
EP1986706B1
(en)
*
|
2006-01-30 |
2011-08-17 |
Biosphere Medical, Inc. |
Porous intravascular embolization particles and methods of making them
|
EP1986707A2
(en)
|
2006-01-30 |
2008-11-05 |
Surgica Corporation |
Compressible intravascular embolization particles and related methods and delivery systems
|
JP2007279028A
(ja)
*
|
2006-03-13 |
2007-10-25 |
Mitsubishi Chemicals Corp |
孔を有する生体物質構造体及びその製造方法、並びに、それを用いた生体物質担持体、対象物質の精製方法、アフィニティークロマトグラフィー用容器、分離用チップ、対象物質の解析方法、対象物質の解析用分離装置、及びセンサーチップ
|
EP2944382A1
(en)
|
2006-04-26 |
2015-11-18 |
Micell Technologies, Inc. |
Coatings containing multiple drugs
|
EP2647712A3
(en)
|
2006-08-04 |
2013-11-20 |
Baxter International Inc |
Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
|
US11426494B2
(en)
|
2007-01-08 |
2022-08-30 |
MT Acquisition Holdings LLC |
Stents having biodegradable layers
|
EP2111184B1
(en)
|
2007-01-08 |
2018-07-25 |
Micell Technologies, Inc. |
Stents having biodegradable layers
|
US9433516B2
(en)
|
2007-04-17 |
2016-09-06 |
Micell Technologies, Inc. |
Stents having controlled elution
|
WO2008131129A2
(en)
|
2007-04-17 |
2008-10-30 |
Baxter International Inc. |
Nucleic acid microparticles for pulmonary delivery
|
US20090098110A1
(en)
*
|
2007-05-30 |
2009-04-16 |
Duke University |
Injectable forms of solid-forming crosslinked bioelastic biopolymers for local drug delivery
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
AU2008261102B2
(en)
|
2007-06-04 |
2013-11-28 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
ES2527070T3
(es)
|
2007-07-13 |
2015-01-19 |
Cc-Ery Gmbh |
Micropartículas, sustituto sanguíneo y procedimiento de formación de los mismos
|
JP2010536341A
(ja)
|
2007-08-15 |
2010-12-02 |
アムニクス, インコーポレイテッド |
生物学的に活性なポリペプチドの特性を改変するための組成物および方法
|
JP2011500054A
(ja)
*
|
2007-10-15 |
2011-01-06 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
安定な保存用中間体を使用した生物製剤の製造方法
|
US8506933B2
(en)
*
|
2007-11-30 |
2013-08-13 |
Msdx, Inc. |
Methods of detecting a neurological condition via analysis of circulating phagocytes
|
MX350637B
(es)
|
2008-04-17 |
2017-09-11 |
Micell Technologies Inc |
Stents que tienen capas bioabsorbibles.
|
DK2982753T3
(da)
|
2008-04-18 |
2018-09-03 |
Baxter Int |
Mikrosfære-baseret sammensætning til at forebygge og/eller reversere nystartet autoimmun diabetes
|
EP2278999A4
(en)
|
2008-04-21 |
2015-04-22 |
Otonomy Inc |
EARLY TREATMENT FORMULATIONS FOR THE TREATMENT OF EARLY DISEASES AND DRESSES
|
US9602777B2
(en)
|
2008-04-25 |
2017-03-21 |
Roche Diagnostics Hematology, Inc. |
Systems and methods for analyzing body fluids
|
JP2012515931A
(ja)
|
2008-04-25 |
2012-07-12 |
ウィンケルマン、ジェイムズ |
全血球数及び白血球百分率を決定するシステム及び方法
|
WO2009149279A2
(en)
*
|
2008-06-04 |
2009-12-10 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
ES2559840T3
(es)
|
2008-06-04 |
2016-02-16 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
EP3241839B1
(en)
|
2008-07-16 |
2019-09-04 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
EP2313122B1
(en)
|
2008-07-17 |
2019-03-06 |
Micell Technologies, Inc. |
Drug delivery medical device
|
CN102105133B
(zh)
|
2008-07-21 |
2015-06-17 |
奥德纳米有限公司 |
控制释放型耳结构调节和先天性免疫系统调节组合物以及治疗耳部病症的方法
|
US8784870B2
(en)
*
|
2008-07-21 |
2014-07-22 |
Otonomy, Inc. |
Controlled release compositions for modulating free-radical induced damage and methods of use thereof
|
US8323615B2
(en)
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing multi-phasic dispersions
|
US8367427B2
(en)
|
2008-08-20 |
2013-02-05 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US8323685B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US20110212179A1
(en)
*
|
2008-10-30 |
2011-09-01 |
David Liu |
Micro-spherical porous biocompatible scaffolds and methods and apparatus for fabricating same
|
CA2994066A1
(en)
*
|
2008-12-03 |
2010-06-10 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase c agonists and methods of use
|
US20110046060A1
(en)
|
2009-08-24 |
2011-02-24 |
Amunix Operating, Inc., |
Coagulation factor IX compositions and methods of making and using same
|
MX2011008094A
(es)
|
2009-02-03 |
2012-02-13 |
Amunix Operating Inc |
Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos.
|
JP2012522589A
(ja)
|
2009-04-01 |
2012-09-27 |
ミシェル テクノロジーズ,インコーポレイテッド |
被覆ステント
|
EP2453834A4
(en)
|
2009-07-16 |
2014-04-16 |
Micell Technologies Inc |
MEDICAL DEVICE DISPENSING MEDICINE
|
EP2493918A4
(en)
|
2009-10-30 |
2013-04-10 |
Ntf Therapeutics Inc |
IMPROVED NEURTURINE MOLECULES
|
WO2011066460A1
(en)
*
|
2009-11-27 |
2011-06-03 |
Msdx, Inc. |
Methods of detecting or monitoring activity of an inflammatory or neurodegenerative condition
|
EP2531140B1
(en)
|
2010-02-02 |
2017-11-01 |
Micell Technologies, Inc. |
Stent and stent delivery system with improved deliverability
|
WO2011133655A1
(en)
|
2010-04-22 |
2011-10-27 |
Micell Technologies, Inc. |
Stents and other devices having extracellular matrix coating
|
WO2012009684A2
(en)
|
2010-07-16 |
2012-01-19 |
Micell Technologies, Inc. |
Drug delivery medical device
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
EP2621509A4
(en)
|
2010-09-15 |
2016-08-03 |
Synergy Pharmaceuticals Inc |
PREPARATIONS OF GUANYLATE CYCLASE-C AGONISTS AND METHODS OF USE
|
US9111343B2
(en)
|
2011-01-18 |
2015-08-18 |
Roche Diagnostics Hematology, Inc. |
Microscope slide coordinate system registration
|
US8673309B2
(en)
|
2011-02-11 |
2014-03-18 |
Msdx, Inc. |
Methods for measuring high molecular weight complexes of fibrinogen with fibronectin and fibulin-1
|
CA2841360A1
(en)
|
2011-07-15 |
2013-01-24 |
Micell Technologies, Inc. |
Drug delivery medical device
|
US10188772B2
(en)
|
2011-10-18 |
2019-01-29 |
Micell Technologies, Inc. |
Drug delivery medical device
|
US9603907B2
(en)
|
2012-02-01 |
2017-03-28 |
Protalix Ltd. |
Dry powder formulations of dNase I
|
HUE046848T2
(hu)
|
2012-02-15 |
2020-03-30 |
Bioverativ Therapeutics Inc |
VIII. faktor készítmények és eljárások elõállításukra és alkalmazásukra
|
EP2822577B1
(en)
|
2012-02-15 |
2019-02-06 |
Bioverativ Therapeutics Inc. |
Recombinant factor viii proteins
|
WO2014005103A2
(en)
|
2012-06-28 |
2014-01-03 |
Ansun Biopharma, Inc. |
Microparticle formulations for delivery to the lower and central respiratory tract and methods of manufacture
|
CA2877774C
(en)
|
2012-07-12 |
2017-07-18 |
Mallinckrodt Llc |
Extended release, abuse deterrent pharmaceutical compositions
|
ES2640363T3
(es)
*
|
2012-11-15 |
2017-11-02 |
Utah-Inha Dds & Advanced Therapeutics Research Center |
Microgránulos biodegradables con capacidad de adsorción mejorada de fármacos anticancerígenos, que contienen albúmina y sulfato de dextrano, y método para su preparación
|
CN104994841B
(zh)
|
2012-11-27 |
2018-11-16 |
犹他-仁荷Dds及新医疗技术开发共同研究所 |
包含阴离子性高分子的抗癌药吸附能力得到提高的生物降解性微珠及其的制备方法
|
JP6330024B2
(ja)
|
2013-03-12 |
2018-05-23 |
マイセル・テクノロジーズ,インコーポレイテッド |
生体吸収性バイオメディカルインプラント
|
US9708367B2
(en)
|
2013-03-15 |
2017-07-18 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase and their uses
|
JP6169255B2
(ja)
|
2013-05-02 |
2017-07-26 |
ビーエーエスエフ ソシエタス・ヨーロピアBasf Se |
ポリアリールエーテルスルホンコポリマー
|
US10272606B2
(en)
|
2013-05-15 |
2019-04-30 |
Micell Technologies, Inc. |
Bioabsorbable biomedical implants
|
US10548953B2
(en)
|
2013-08-14 |
2020-02-04 |
Bioverativ Therapeutics Inc. |
Factor VIII-XTEN fusions and uses thereof
|
US10987308B2
(en)
|
2014-09-03 |
2021-04-27 |
Genesegues, Inc. |
Therapeutic nanoparticles and related compositions, methods and systems
|
US20170304459A1
(en)
|
2014-10-10 |
2017-10-26 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
CN108368502B
(zh)
|
2015-06-03 |
2022-03-18 |
内布拉斯加大学董事委员会 |
使用单链dna的dna编辑
|
KR20180037994A
(ko)
|
2015-07-28 |
2018-04-13 |
오토노미, 인코포레이티드 |
TrkB 또는 TrkC 아고니스트 조성물 및 귀 병태의 치료 방법
|
IL257231B
(en)
|
2015-08-03 |
2022-09-01 |
Bioverativ Therapeutics Inc |
Factor ix fusion proteins and methods for their preparation and use
|
CN109689027A
(zh)
|
2016-06-29 |
2019-04-26 |
奥德纳米有限公司 |
甘油三酯耳用制剂及其用途
|
WO2018031771A1
(en)
|
2016-08-11 |
2018-02-15 |
University Of Iowa Research Foundation |
CATIONIC CaMKII INHIBITING NANOPARTICLES FOR THE TREATMENT OF ALLERGIC ASTHMA
|
EP4045152A1
(en)
|
2019-10-15 |
2022-08-24 |
Cornell University |
Methods for modulating level of expression from gene therapy expression cassette
|
CN114761569A
(zh)
|
2019-10-16 |
2022-07-15 |
康奈尔大学 |
阿尔茨海默氏病的基因疗法
|
US20230001017A1
(en)
|
2019-10-28 |
2023-01-05 |
University Of Lowa Research Foundation |
Formulation for delivery of lubricin gene
|
CA3162761A1
(en)
|
2019-11-25 |
2021-06-03 |
Cornell University |
Apoe gene therapy
|
US20230158125A1
(en)
|
2020-04-20 |
2023-05-25 |
Sorrento Therapeutics, Inc. |
Pulmonary Administration of ACE2 Polypeptides
|
IL297486A
(en)
|
2020-04-23 |
2022-12-01 |
Univ Iowa Res Found |
gper-targeted chimeras of protein degradation
|
US20230293678A1
(en)
|
2020-08-21 |
2023-09-21 |
Aliasger K. Salem |
Cationic nanoparticle adjuvants
|
US20230414787A1
(en)
|
2020-08-27 |
2023-12-28 |
University Of Iowa Research Foundation |
Gene knock-out for treatment of glaucoma
|
WO2022125963A1
(en)
|
2020-12-11 |
2022-06-16 |
University Of Iowa Research Foundation |
Compositions comprising molecules for cystic fibrosis treatment
|
WO2022246280A1
(en)
|
2021-05-21 |
2022-11-24 |
University Of Iowa Research Foundation |
Anti-oxidant containing particles and methods of use
|
WO2022271951A1
(en)
|
2021-06-23 |
2022-12-29 |
University Of Iowa Research Foundation |
Sustained release formulations comprising a selective androgen receptor modulator
|